Latest Europe News

Anteris Technologies Global Corp. reported a $42.7 million net loss for the first half of 2025 amid advancing preparations for its pivotal DurAVR Transcatheter Heart Valve trial. The company’s recent IPO proceeds are fueling R&D and manufacturing scale-up as it targets regulatory approvals.

Carnegie Clean Energy launches a $3 million Share Purchase Plan at a 20% discount to fund its pioneering 6 MW CETO wave energy project in Spain and expand its global footprint.

GBM Resources has appointed Daniel Hastings as its new CEO, bringing 25 years of global mining expertise to drive strategic growth and operational excellence.

PM Capital Global Opportunities Fund Limited reported a robust 33.98% rise in profit after tax to $168.2 million for FY25, alongside a raised fully franked final dividend of 6.0 cents per share. The fund’s portfolio outperformed key benchmarks, reflecting strategic positioning amid structural global economic changes.

AVITA Medical has filed its Q2 2025 Form 10-Q, reaffirming its leadership in acute wound care with its FDA-approved RECELL System and expanding international footprint.

Orbital Corporation has denied any undisclosed information behind its recent share price jump, attributing market interest to strategic leadership appointments aimed at expanding its UAV propulsion business.

Vection Technologies has reported its first positive underlying EBITDA for FY2025, driven by strong growth in its Defence sector. The company sets ambitious FY2026 revenue targets of $70 million, underpinned by a robust $50 million sales pipeline and cutting-edge AI and spatial computing solutions.

AVITA Medical’s Q2 2025 update reveals a temporary setback in RECELL demand due to Medicare reimbursement delays, offset by strong revenue growth and promising clinical data. The company anticipates recovery and renewed growth in the second half of the year.

QBE Insurance Group reported a robust half-year performance with a 28% rise in adjusted net profit and solid premium growth, underpinning a confident outlook for 2025.

Neuren Pharmaceuticals reports a 16% rise in Q2 2025 royalties driven by Acadia’s DAYBUE sales growth and expanding patient base in the US. Full-year sales guidance remains strong with European market entry on the horizon.

Energy Transition Minerals Ltd (ETM) has won the bid for the Penouta mine in Spain, the EU’s sole tin-tantalum-niobium producer, raising A$10 million to support the acquisition and development amid regulatory hurdles.

Prophecy International and Complexica announce a strategic merger to form MergeCo, an ASX-listed AI pure play with enhanced scale, product synergies, and growth potential.